- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2020–2026 · research · R01
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
Nancy Y Lee · Kettering University · funded by National Institutes of Health
2020–2021 · grant · Standard Grant
RAPID: Identifying Biophysical Determinants of Binding to the SARS-CoV-2 Main Viral Protease
John Chodera · Kettering University · funded by National Science Foundation
2020–2025 · research · R01
Toward development of senolytic CAR T cells
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
Joan Massague · Kettering University · funded by National Institutes of Health
2020–2025 · program · P50
MSK SPORE in Genomic Instability in Breast Cancer
Simon N. Powell · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer
Andrew Chow · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Tumor-Selective Delivery Approaches for Medulloblastoma
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
Joan Massague · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Development and validation of an intraoperative imaging agent for the peripheral nervous system
Nagavarakishore Pillarsetty · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Lipid programs in melanocyte transformation
Richard Mark White · Kettering University · funded by National Institutes of Health
2020–2023 · research · R21
Radiotherapy-associated breast cancer: machine learning on genotypes to predict individualized risk
Jonine L. Bernstein · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
Oguz Akin · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa
Maria E Arcila · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Investigating microRNA Function in Homeostasis, Regeneration and Cancer
Andrea Ventura · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
David A Scheinberg · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
Andrea Cercek · Kettering University · funded by National Institutes of Health
2020–2023 · fellowship · F32
Mechanisms of ATM activation by the MRN complex and DNA Double Strand Breaks
Christopher Warren · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Tumor-Selective Delivery Approaches for Medulloblastoma
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Tumor-Selective Delivery Approaches for Medulloblastoma
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Regulation of tumor suppression by alpha-ketoglutarate
Lydia Finley · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
Sydney X Lu · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
Investigating histone glycation as a new dynamic epigenetic mark
Yael E David-Shternberg · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
The TGF Beta Signaling Pathway in Development and Cancer
Joan Massague · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
Michelle S Bradbury · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
David A Scheinberg · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Comparative Modeling of Effective Policies for Colorectal Cancer Control
Amy Knudsen · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Tumor-Selective Delivery Approaches for Medulloblastoma
Daniel Alan Heller · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Exercise as Interception Therapy in Primary High Risk Cancer
Luis A Diaz · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Interrogating the minor spliceosome to understand and treat leukemia
Omar Abdel-Wahab · Kettering University · funded by National Institutes of Health
2020–2023 · research · R01
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
Michelle S Bradbury · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Towards targeting the lymphoma microenvironment
Hans-Guido Wendel · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Visualizing oxidative stress using hyperpolarized magnetic resonance
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2020–2022 · fellowship · F31
3'UTR-dependent regulation of the PTEN tumor suppressor gene
Ellen Horste · Kettering University · funded by National Institutes of Health
2020–2022 · fellowship · F31
3'UTR-dependent regulation of the PTEN tumor suppressor gene
Ellen Horste · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Investigating microRNA Function in Homeostasis, Regeneration and Cancer
Andrea Ventura · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia
Scott E James · Kettering University · funded by National Institutes of Health